Skip to Content

AroCell AB 80R

Morningstar Rating
SEK 0.03 0.00 (6.49%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

80R is trading at a 395% premium.
Price
€0.03
Fair Value
€5.29
Uncertainty
Extreme
1-Star Price
€8.14
5-Star Price
€3.24
Economic Moat
Vzdv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 80R is a good fit for your portfolio.

Trading Information

Previous Close Price
SEK 0.03
Day Range
SEK 0.020.03
52-Week Range
SEK 0.020.57
Bid/Ask
SEK 0.00 / SEK 0.00
Market Cap
SEK 6.63 Mil
Volume/Avg
0 /

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.70
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
28

Valuation

Metric
80R
Price/Earnings (Normalized)
Price/Book Value
0.50
Price/Sales
1.70
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
80R
Quick Ratio
5.16
Current Ratio
5.78
Interest Coverage
Quick Ratio
80R

Profitability

Metric
80R
Return on Assets (Normalized)
−29.36%
Return on Equity (Normalized)
−31.19%
Return on Invested Capital (Normalized)
−31.61%
Return on Assets
80R
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
TdftcnmbdGxp$218.4 Bil
Danaher Corp
DHR
LpsbhqywxLmwbyw$188.8 Bil
IDEXX Laboratories Inc
IDXX
RvfrmsdvVjcjvr$41.6 Bil
IQVIA Holdings Inc
IQV
RmynfxnFxvyksg$38.8 Bil
Agilent Technologies Inc
A
QwpqwngtDccq$37.9 Bil
Mettler-Toledo International Inc
MTD
JnjqsbjcfVkrfpv$31.1 Bil
Icon PLC
ICLR
JxzkjmlXvcjs$25.9 Bil
Waters Corp
WAT
WpcnwrlqgVtsy$17.5 Bil
Illumina Inc
ILMN
YlbtvgfLwtxpq$17.3 Bil
Labcorp Holdings Inc
LH
SxqggdshpJwfgk$16.8 Bil

Sponsor Center